A novel radioligand for imaging the AT1 angiotensin receptor with PET

2-Butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine (KR31173) was radiolabeled by coupling a tetrazole-protected hydroxy precursor with [(11)C] methyl iodide and removing the protecting group by acid hydrolysis. In mice, the hig...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nuclear medicine and biology 2004-07, Vol.31 (5), p.571-574
Hauptverfasser:	Mathews, William B, Yoo, Sung-Eun, Lee, Sung-Hou, Scheffel, Ursula, Rauseo, Paige A, Zober, Tamas G, Gocco, Gerard, Sandberg, Kathryn, Ravert, Hayden T, Dannals, Robert F, Szabo, Zsolt
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Glands - diagnostic imaging Adrenal Glands - metabolism Animals Carbon Radioisotopes - pharmacokinetics Imidazoles - pharmacokinetics Kidney - diagnostic imaging Kidney - metabolism Ligands Liver - diagnostic imaging Liver - metabolism Male Mice Organ Specificity Positron-Emission Tomography - methods Radiopharmaceuticals - pharmacokinetics Receptor, Angiotensin, Type 1 - metabolism Reproducibility of Results Sensitivity and Specificity Tetrazoles - pharmacokinetics Tissue Distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	2-Butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine (KR31173) was radiolabeled by coupling a tetrazole-protected hydroxy precursor with [(11)C] methyl iodide and removing the protecting group by acid hydrolysis. In mice, the highest uptake of [(11)C] KR31173 was in the adrenal glands, kidneys, and liver. Tissue to blood ratios were generally greater than 10:1. Uptake of the tracer in the adrenal glands, kidneys, lungs, and heart was blocked with a 1 mg/kg dose of KR31173 or MK-996.
ISSN:	0969-8051
DOI:	10.1016/j.nucmedbio.2003.10.014